Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Travellers' diarrhoea - prevention, trends and role of microbiome

R. Danis, M. Wawruch

. 2022 ; 30 (1) : 20-25. [pub] -

Language English Country Czech Republic

Document type Journal Article, Review

Digital library NLK
Source

E-resources Online Full text

NLK Free Medical Journals from 2004
ProQuest Central from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost) from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest) from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest) from 2009-03-01 to 6 months ago
Public Health Database (ProQuest) from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources from 1993

OBJECTIVES: In this review, we present a contemporary look at the management of travellers' diarrhoea (TD), and we discuss the potential role of a microbiome as well as the administration of live microorganisms in order to prevent TD. METHODS: We performed a comprehensive search using the PubMed and Web of Science databases for the period 2014-2021, looking for original and review articles on travellers' diarrhoea. RESULTS: TD belongs among the most frequent illnesses experienced by travellers. For the most part, it is manifested as an acute yet self limiting condition, and only in a few cases proceeds to a prolonged form. Epidemiological analyses have shown that the majority of TD cases are caused by bacterial infections. In practice, pharmacological therapy is often used in the prevention and treatment of TD, since patients naturally seek preventive measures against the development of its severe course and its impact on planned activities. Bismuth salicylate is a strongly recommended TD prophylaxis but is not available on all European Union markets. Although the antibiotic prophylaxis is not generally recommended in guidelines, some antibiotic or chemotherapeutic agents are accessible over-the-counter in certain countries, and travellers are routinely encouraged to use them preventively. This routine can alter the microbiome of the traveller and promote the spread of drug resistant bacteria in their place of residence. Probiotic administration is considered safe, although the quality of evidence in favour of its prophylactic use in TD is currently low. CONCLUSIONS: The challenge for public health authorities is to educate personnel that can directly influence the behaviour of travellers through safe and effective pharmacological alternatives to antibiotics. Manipulation of the gut microbiome using specific probiotic strains can represent a safe and promising intervention.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22013084
003      
CZ-PrNML
005      
20220622160508.0
007      
ta
008      
220504s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a6740 $2 doi
035    __
$a (PubMed)35421294
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Danis, Radoslav $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic
245    10
$a Travellers' diarrhoea - prevention, trends and role of microbiome / $c R. Danis, M. Wawruch
520    9_
$a OBJECTIVES: In this review, we present a contemporary look at the management of travellers' diarrhoea (TD), and we discuss the potential role of a microbiome as well as the administration of live microorganisms in order to prevent TD. METHODS: We performed a comprehensive search using the PubMed and Web of Science databases for the period 2014-2021, looking for original and review articles on travellers' diarrhoea. RESULTS: TD belongs among the most frequent illnesses experienced by travellers. For the most part, it is manifested as an acute yet self limiting condition, and only in a few cases proceeds to a prolonged form. Epidemiological analyses have shown that the majority of TD cases are caused by bacterial infections. In practice, pharmacological therapy is often used in the prevention and treatment of TD, since patients naturally seek preventive measures against the development of its severe course and its impact on planned activities. Bismuth salicylate is a strongly recommended TD prophylaxis but is not available on all European Union markets. Although the antibiotic prophylaxis is not generally recommended in guidelines, some antibiotic or chemotherapeutic agents are accessible over-the-counter in certain countries, and travellers are routinely encouraged to use them preventively. This routine can alter the microbiome of the traveller and promote the spread of drug resistant bacteria in their place of residence. Probiotic administration is considered safe, although the quality of evidence in favour of its prophylactic use in TD is currently low. CONCLUSIONS: The challenge for public health authorities is to educate personnel that can directly influence the behaviour of travellers through safe and effective pharmacological alternatives to antibiotics. Manipulation of the gut microbiome using specific probiotic strains can represent a safe and promising intervention.
650    _2
$a antibakteriální látky $x terapeutické užití $7 D000900
650    12
$a průjem $x prevence a kontrola $7 D003967
650    _2
$a lidé $7 D006801
650    12
$a mikrobiota $7 D064307
650    _2
$a cestování $7 D014195
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Wawruch, Martin $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 30, č. 1 (2022), s. 20-25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35421294 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20220504 $b ABA008
991    __
$a 20220622160503 $b ABA008
999    __
$a ok $b bmc $g 1806522 $s 1164292
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 30 $c 1 $d 20-25 $e - $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
LZP    __
$b NLK138 $a Pubmed-20220504

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...